Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | |
| Cash Flows From Operating Activities | |
| Net Income | -1,652 |
| Depreciation Amortization | 52 |
| Other Working Capital | 28 |
| Other Operating Activity | 843 |
| Operating Cash Flow | $-729 |
| Cash Flows From Investing Activities | |
| PPE Investments | -18 |
| Investing Cash Flow | $-18 |
| Cash Flows From Financing Activities | |
| Debt Repayment | -2 |
| Common Stock Issued | 1,236 |
| Financing Cash Flow | $1,234 |
| Beginning Cash Position | 39 |
| End Cash Position | 526 |
| Net Cash Flow | $487 |
| Free Cash Flow | |
| Operating Cash Flow | -729 |
| Capital Expenditure | -18 |
| Free Cash Flow | -747 |